New online program aims to ease emotional burden for women battling lung cancer
NCT ID NCT03731585
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an online program called BREATHE for women with non-small cell lung cancer. The program uses mindfulness, compassion, and emotional processing to help improve social well-being and reduce distress. About 70 women will participate, and the main goal is to see if the program is practical and acceptable, not yet whether it works for symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Online psychosocial intervention (mindfulness, compassion, emotional processing sessions)
- What this could lead to
- If successful, this could provide a practical online tool to help women with lung cancer feel less distressed and more supported during treatment.
- What could go wrong
- This is a small, early-stage feasibility study (70 participants) focused on whether the program is acceptable and usable, not on proving it works. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
70 people
The number who actually took part.
- Started
-
Nov 2018
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women diagnosed with stage I-IV non-small cell lung cancer within 3 months of diagnosis at the time of recruitment and receiving any type of treatment at the time of recruitment. For women with metastatic disease, disease must be stable (without disease progression based on patients' latest imaging impressions) per treating oncologist * Eastern Cooperative Oncology Group (ECOG) performance status of =\< 2 * Have access to the internet * Able to read, write and speak English Exclusion Criteria: * Major psychiatric or cognitive deficits that would impede the completion of self-report instruments as deemed by the clinical team * Regular (self-defined) participation in psychotherapy or a formal cancer support group
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non small cell lung carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict and treat cancer wasting better? a new study investigates
- Can a targeted pill keep lung cancer from returning?
- Seeing Cancer's hidden markers: a new PET tracer could reveal who responds to targeted therapy
- Facing the fear: a new program aims to ease anxiety in advanced cancer
- Can a Chemo-Immunotherapy duo outsmart tough lung cancer?
- Radiation hotspots may boost lung cancer treatment — a trial puts it to the test